Sunrise strengthens partnership with IDI FARMACEUTICI with the distribution of 3 new dermatological products
We are excited to announce that Sunrise has extended its collaboration with IDI FARMACEUTICI, through a new agreement for the distribution of:
- SCEVADIL CUTANIC SOLUTION 1 FLACON 60 ml 50 mg/ml
- SCEVADIL CUTANIC SOLUTION 3 FLACONS 60 ml 50 mg/ml
- ALOXIDIL CUTANIC SOLUTION 3 FLACONS 60 ml 20 mg/ml
This new concession expands our offering, further consolidating our commitment to providing high-quality therapeutic solutions to support patients’ health.
The new drugs, which belong to the category of dermatological drugs and are in addition to those already in distribution, will help enrich the landscape of treatments available to practitioners and patients.
This agreement marks another step forward in the solid and fruitful collaboration with IDI FARMACEUTICI, consolidating our reference position in the Italian market. We are proud to continue working together to bring innovation and quality to our customers.